Photostability of pitavastatin-A novel HMG-CoA reductase inhibitor

被引:21
|
作者
Grobelny, Pawel [2 ]
Viola, Giampietro [3 ]
Vedaldi, Daniela [4 ]
Dall'Acqua, Francesco [4 ]
Gliszczynska-Swiglo, Anna [5 ]
Mielcarek, Jadwiga [1 ]
机构
[1] Poznan Univ Med Sci, Dept Inorgan & Analyt Chem, PL-60780 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Pharmaceut Technol, PL-60780 Poznan, Poland
[3] Univ Padua, Dept Pediat, Oncohematol Lab, I-35131 Padua, Italy
[4] Univ Padua, Dept Pharmaceut Sci, I-35128 Padua, Italy
[5] Poznan Univ Econ, Fac Commod Sci, PL-60967 Poznan, Poland
关键词
Statins; HMG-CoA reductase inhibitors; Pitavastatin; Photostability; Photodegradation; STATINS; STABILITY; WATER; ROSUVASTATIN; FORMULATION; SAFETY; PLASMA;
D O I
10.1016/j.jpba.2008.10.004
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The photostability of pitavastatin, an HMG-CoA reductase inhibitor used in the treatment of hypercholesterolemia, was investigated. The sample solution was exposed to UV-A radiation and the photodegradation process was monitored by means of spectro photometric method and HPLC-DAD. Pitavastatin was shown to be photolabile and its photodegradation reaction followed the first-order kinetics with the rate constant k = 3.54 x 10(-4) +/- 9.43 x 10(-6) s(-1). The chromatograms revealed the presence of four major photoproducts (PP-1-PP-4). The separated and isolated photolytic products were identified using a mass spectrometer coupled with a time of flight (TOF) analyzer. The main reaction observed during exposure to radiation of pitavastatin was photocyclisation leading to formation of four-ring photoproducts. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 50 条
  • [1] Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
    Watson, Karol E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2010, 11 (01) : 28 - 34
  • [2] Pitavastatin: A New HMG-CoA Reductase Inhibitor
    Wensel, Terri M.
    Waldrop, Bruce A.
    Wensel, Brian
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
  • [3] Pitavastatin: Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor
    Kajinami, K
    Takekoshi, N
    Saito, Y
    CARDIOVASCULAR DRUG REVIEWS, 2003, 21 (03): : 199 - 215
  • [4] New and efficient synthesis of the HMG-CoA reductase inhibitor pitavastatin
    Acemoglu, Murat
    Brodbeck, Andre
    Garcia, Angel
    Grimler, Dorninique
    Hassel, Marc
    Riss, Bernhard
    Schreiber, Robert
    HELVETICA CHIMICA ACTA, 2007, 90 (06) : 1069 - 1081
  • [5] Pitavastatin A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia
    Ahmad, Haniyyah
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2010, 18 (05) : 264 - 267
  • [6] Pitavastatin (NK-104), a new HMG-CoA reductase inhibitor
    Isley, WL
    DRUGS OF TODAY, 2001, 37 (09) : 587 - 594
  • [7] Inhibition of Intestinal Polyp Formation by Pitavastatin, a HMG-CoA Reductase Inhibitor
    Teraoka, Naoya
    Mutoh, Michihiro
    Takasu, Shinji
    Ueno, Toshiya
    Yamamoto, Masafumi
    Sugimura, Takashi
    Wakabayashi, Keiji
    CANCER PREVENTION RESEARCH, 2011, 4 (03) : 445 - 453
  • [8] SYNTHESIS OF A NOVEL HMG-COA REDUCTASE INHIBITOR
    BAADER, E
    BARTMANN, W
    BECK, G
    BERGMANN, A
    JENDRALLA, H
    KESSELER, K
    WESS, G
    SCHUBERT, W
    GRANZER, E
    VONKEREKJARTO, B
    KRAUSE, R
    TETRAHEDRON LETTERS, 1988, 29 (08) : 929 - 930
  • [9] Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
    Yoshida, Osamu
    Kondo, Takahisa
    Kureishi-Bando, Yasuko
    Sugiura, Tomonori
    Maeda, Kengo
    Okumura, Kenji
    Murohara, Toyoaki
    CIRCULATION JOURNAL, 2010, 74 (01) : 195 - 202
  • [10] Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase
    Fujino, H
    Nakai, D
    Nakagomi, R
    Saito, M
    Tokui, T
    Kojima, J
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2004, 54 (07): : 382 - 388